Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04688554 · ClinicalTrials.gov registry record
Psychosocial, Behavioral, and Radiologic Changes Following Radiosurgery for Benign Neurologic Disease
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 18
- Enrollment target
NCT04688554: Completed study, sponsored by Vanderbilt University Medical Center.
NCT04688554 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04688554 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
A number of studies from the literature suggest important behavioral, psychosocial, or radiologic changes occur following significant neurologic events or interventions such as stroke, neurosurgery, medications, radiation, systemic therapy, or injury. The purpose of this study is to describe these changes with advanced neurologic imaging and targeted neurologic and neuropsychiatric assessments. This is a non-interventional observational study of minimal risk to participants as there is no medical intervention. The results of this study will be used to inform patients, scientists, and society in the development of future treatments.
Primary Outcome
Yale-Brown Obsessive Compulsive Scale questionnaire
Interventions
- DIAGNOSTIC_TEST fMRI and DTI
- BEHAVIORAL Behavioral questionnaires
- BEHAVIORAL Disease-Specific Patient-Reported Outcomes
- BEHAVIORAL Behavioral tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2020-08-25 |
| Est. Completion | 2024-02-01 |
What the finished NCT04688554 record still lists
NCT04688554 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which fMRI and DTI is the first listed.
NCT04688554 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04688554 about?
NCT04688554 is a clinical study titled "Psychosocial, Behavioral, and Radiologic Changes Following Radiosurgery for Benign Neurologic Disease". A number of studies from the literature suggest important behavioral, psychosocial, or radiologic changes occur following significant neurologic events or interventions such as stroke, neurosurgery, medications, radiation, systemic therapy, or injury. The purpose of this study is to describe these c...
What is the current status of trial NCT04688554?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2020-08-25. Estimated completion is 2024-02-01.
What interventions are being tested in trial NCT04688554?
The interventions under investigation include: fMRI and DTI (DIAGNOSTIC_TEST), Behavioral questionnaires (BEHAVIORAL), Disease-Specific Patient-Reported Outcomes (BEHAVIORAL), Behavioral tests (BEHAVIORAL).
Who is sponsoring clinical trial NCT04688554?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI